Skip to Content
Merck
CN

03665

Ethylenediaminetetraacetic acid tripotassium salt dihydrate

≥96.0% (KT)

Synonym(s):

EDTA tripotassium salt, Edathamil, Tripotassium ethylenediaminetetraacetate dihydrate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
(KOOCCH2)2NCH2CH2N(CH2COOK)CH2COOH · 2H2O
CAS Number:
Molecular Weight:
442.54
PubChem Substance ID:
UNSPSC Code:
12352100
Beilstein/REAXYS Number:
6762497
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

≥96.0% (KT)

mp

182 °C (dec.) (lit.)

SMILES string

[K+].[K+].[K+].[H]O[H].[H]O[H].OC(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O

InChI

1S/C10H16N2O8.3K.2H2O/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;;2*1H2/q;3*+1;;/p-3

InChI key

MAPFUJCWRWFQIY-UHFFFAOYSA-K

Application

Used to eliminate inhibition of enzyme catalyzed reactions due to traces of heavy metals


Still not finding the right product?


pictograms

Health hazardExclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Inhalation - STOT RE 2 Inhalation

target_organs

Respiratory Tract

Storage Class

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Justin P Dassie et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 22(11), 1910-1922 (2014-06-24)
Cell-targeted therapies (smart drugs), which selectively control cancer cell progression with limited toxicity to normal cells, have been developed to effectively treat some cancers. However, many cancers such as metastatic prostate cancer (PC) have yet to be treated with current